178 related articles for article (PubMed ID: 31258779)
1. CBX2 Regulates Proliferation and Apoptosis via the Phosphorylation of YAP in Hepatocellular Carcinoma.
Mao J; Tian Y; Wang C; Jiang K; Li R; Yao Y; Zhang R; Sun D; Liang R; Gao Z; Wang Q; Wang L
J Cancer; 2019; 10(12):2706-2719. PubMed ID: 31258779
[TBL] [Abstract][Full Text] [Related]
2. CBX2 depletion inhibits the proliferation, invasion and migration of gastric cancer cells by inactivating the YAP/β-catenin pathway.
Zeng M; Li B; Yang L; Guan Q
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33313949
[TBL] [Abstract][Full Text] [Related]
3. [Studies on the role of chromobox protein homolog 2 in the inhibition of progression of hepatoma].
Li J; Guo ZX; Chen JA; Xue C; Sun LL; Ren ZG; Li A; Cui GY; Yu ZJ
Zhonghua Gan Zang Bing Za Zhi; 2019 Mar; 27(3):192-197. PubMed ID: 30929335
[No Abstract] [Full Text] [Related]
4. [The expression and significance of chromobox protein homolog 2 in breast cancer].
Guo XH; Zhang JY; Jiao DC; Zhu JJ; Ma YZ; Yang Y; Xiao H; Liu ZZ
Zhonghua Yi Xue Za Zhi; 2020 Jan; 100(2):130-135. PubMed ID: 31937053
[No Abstract] [Full Text] [Related]
5. Prognostic hub gene CBX2 drives a cancer stem cell-like phenotype in HCC revealed by multi-omics and multi-cohorts.
Meng Q; Zhou Q; Chen X; Chen J
Aging (Albany NY); 2023 Nov; 15(22):12817-12851. PubMed ID: 37980163
[TBL] [Abstract][Full Text] [Related]
6. CBX2-mediated suppression of SIAH2 triggers WNK1 accumulations to promote glycolysis in hepatocellular carcinoma.
Xu Z; Wu Y; Yang M; Wei H; Pu J
Exp Cell Res; 2023 May; 426(1):113513. PubMed ID: 36780970
[TBL] [Abstract][Full Text] [Related]
7. Chromobox homolog 2 protein: A novel biomarker for predicting prognosis and Taxol sensitivity in patients with breast cancer.
Chen WY; Zhang XY; Liu T; Liu Y; Zhao YS; Pang D
Oncol Lett; 2017 Mar; 13(3):1149-1156. PubMed ID: 28454227
[TBL] [Abstract][Full Text] [Related]
8. Identification of hepatocellular carcinoma subtypes based on PcG-related genes and biological relevance with cancer cells.
Fu Y; Yang K; Wu K; Wang H; Li Q; Zhang F; Yang K; Yao Q; Ma X; Deng Y; Zhang J; Liu C; Qu K
Clin Epigenetics; 2022 Dec; 14(1):184. PubMed ID: 36566204
[TBL] [Abstract][Full Text] [Related]
9. CBX2 identified as driver of anoikis escape and dissemination in high grade serous ovarian cancer.
Wheeler LJ; Watson ZL; Qamar L; Yamamoto TM; Post MD; Berning AA; Spillman MA; Behbakht K; Bitler BG
Oncogenesis; 2018 Nov; 7(11):92. PubMed ID: 30478317
[TBL] [Abstract][Full Text] [Related]
10. Expression and prognostic significance of CBX2 in colorectal cancer: database mining for CBX family members in malignancies and vitro analyses.
Zhou H; Xiong Y; Liu Z; Hou S; Zhou T
Cancer Cell Int; 2021 Jul; 21(1):402. PubMed ID: 34321009
[TBL] [Abstract][Full Text] [Related]
11. The hypoxia conditioned mesenchymal stem cells promote hepatocellular carcinoma progression through YAP mediated lipogenesis reprogramming.
Liu Y; Ren H; Zhou Y; Shang L; Zhang Y; Yang F; Shi X
J Exp Clin Cancer Res; 2019 May; 38(1):228. PubMed ID: 31142342
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of CBX2 controls its nucleosome-binding specificity.
Kawaguchi T; Machida S; Kurumizaka H; Tagami H; Nakayama JI
J Biochem; 2017 Nov; 162(5):343-355. PubMed ID: 28992316
[TBL] [Abstract][Full Text] [Related]
13. α-Hederin Inhibits the Proliferation of Hepatocellular Carcinoma Cells
Chen T; Sun D; Wang Q; Zhou T; Tan J; Xu C; Cheng H; Shen W
Front Oncol; 2022; 12():839603. PubMed ID: 35311132
[TBL] [Abstract][Full Text] [Related]
14. The Epigenetic Regulatory Protein CBX2 Promotes mTORC1 Signalling and Inhibits DREAM Complex Activity to Drive Breast Cancer Cell Growth.
Bilton LJ; Warren C; Humphries RM; Kalsi S; Waters E; Francis T; Dobrowinski W; Beltran-Alvarez P; Wade MA
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884550
[TBL] [Abstract][Full Text] [Related]
15. Melatonin Regulates Cisplatin Resistance and Glucose Metabolism Through Hippo Signaling in Hepatocellular Carcinoma Cells.
Mi L; Kuang H
Cancer Manag Res; 2020; 12():1863-1874. PubMed ID: 32210629
[TBL] [Abstract][Full Text] [Related]
16. Novel chromobox 2 inhibitory peptide decreases tumor progression.
Brubaker LW; Backos DS; Nguyen VT; Reigan P; Yamamoto TM; Woodruff ER; Iwanaga R; Wempe MF; Kumar V; Persenaire C; Watson ZL; Bitler BG
Expert Opin Ther Targets; 2023; 27(4-5):361-371. PubMed ID: 37243607
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of YAP inhibits proliferation, invasion and increases cisplatin sensitivity in human hepatocellular carcinoma cells.
Wang X; Wu B; Zhong Z
Oncol Lett; 2018 Jul; 16(1):585-593. PubMed ID: 29928445
[TBL] [Abstract][Full Text] [Related]
18. Loss of CBX2 causes genomic instability and Wnt activation in high grade serous ovarian carcinoma cells.
Ma Y; Liu L; Wei Z; Zhu M; Huang L; Wang S; Yi X; Ying F; Zhao S; Cai J; Wang Z; Sun S
Mol Carcinog; 2023 Apr; 62(4):479-492. PubMed ID: 36621979
[TBL] [Abstract][Full Text] [Related]
19. MACC1 suppresses cell apoptosis in hepatocellular carcinoma by targeting the HGF/c-MET/AKT pathway.
Yao Y; Dou C; Lu Z; Zheng X; Liu Q
Cell Physiol Biochem; 2015; 35(3):983-96. PubMed ID: 25660117
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of CBX2 in breast cancer promotes tumor progression through the PI3K/AKT signaling pathway.
Zheng S; Lv P; Su J; Miao K; Xu H; Li M
Am J Transl Res; 2019; 11(3):1668-1682. PubMed ID: 30972192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
